Development of UV spectrophotometry methods for concurrent quantification of amlodipine and celecoxib by manipulation of ratio spectra in pure and pharmaceutical formulation

Recently, the United States Food and Drug Administration approved a new oral dosage preparation of amlodipine besylate (AML) and celecoxib (CEL) for the management of hypertension and osteoarthritis. However, no simultaneous estimation procedures for these two analytes have been described. Hence, tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Attimarad, Mahesh, Narayanswamy, Venugopla Katarigatta, Aldhubaib, Bandar Essa, SreeHarsha, Nagaraja, Nair, Anroop Balachandran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746368/
https://www.ncbi.nlm.nih.gov/pubmed/31525229
http://dx.doi.org/10.1371/journal.pone.0222526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746368/
https://www.ncbi.nlm.nih.gov/pubmed/31525229
http://dx.doi.org/10.1371/journal.pone.0222526

Ejemplares similares